We have recently produced an updated version of consensus document and recommendations on the follow-up of cutaneous melanoma patients.
(2022 update to the Melanoma Focus 2013 position paper)
A. Gupta, R. Board, P. Corrie, J. Hook, J. Larkin, M. Middleton,
D. Mowatt, P. Nathan, R. Plummer, H. Shaw, A. Waterson, P. Lorigan.
Jaddy Czajka and Elly Castellano for advice on radiation ris
“It is a privilege to lead the Melanoma Focus consensus document and recommendations on the follow-up of cutaneous melanoma patients. The national and international evidence was reviewed to create a position paper to support the UK medical community.”
Dr Avinash Gupta
Consultant Medical Oncologist – Melanoma Team
Christie Associate Medical Director for Digital Services (Medical CCIO)
There have been dramatic changes in the treatment options and clinical outcomes for patients with cutaneous melanoma in the past ten years. This position paper represents an update to the Melanoma Focus 2013 Position Paper, with new recommendations for the follow up of patients with resected Stage II, Stage III and Stage IV melanoma, based on the consensus views of a panel of melanoma experts in the UK. It is intended as a framework to inform clinical teams treating patients with melanoma.
Click here to view the document
The document follows up from the 2013 Melanoma Focus position paper ‘Follow Up of High Risk Cutaneous Melanoma‘. NICE are expected to also publish additional guidance later in 2022.